Methanol Extract of Improves Type 2 Diabetes Mellitus Through Modifying Intestinal Flora

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Jan 23

PMID 36686454

Authors

Xuewei Ye

Kefei Wu

Langyu Xu

Yingxin Cen

Jiahui Ni

Junyao Chen

Wenxin Zheng

Wei Liu

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) poses a significant risk to human health. Previous research demonstrated that possesses good hypolipidemic, anti-inflammatory, and anti-tumor properties. In this research, we aim to investigate the potential treatment outcomes of for T2DM and discuss its favourable influences on the intestinal flora. The chemical composition of methanol extracts (IO) was analyzed by ultra-high-performance liquid chromatography-Q extractive-mass spectrometry. IO significantly improved the blood glucose level, blood lipid level, and inflammatory factor level in T2DM mice, and effectively alleviated the morphological changes of colon, liver and renal. Acetic acid, propionic acid, and butyric acid levels in the feces of the IO group were restored. 16S rRNA gene sequencing revealed that the intestinal flora composition of mice in the IO group was significantly modulated. showed significant hypoglycemic and hypolipidemic effects with evident anti-inflammatory activity and improved the morphological structure of various organs and cells. increased the levels of short-chain fatty acids in the environment by increasing the population of certain bacteria that produce acid, such as and , which are beneficial to improve intestinal flora disorders and maintain intestinal flora homeostasis. Meanwhile, further alleviated T2DM symptoms in db/db mice by down-regulating the high number of microorganisms that are dangerous, such as and and up-regulating the abundance of beneficial bacteria such as and . Therefore, this study provides a new perspective for the treatment of T2DM by demonstrating that drug and food homologous active substances could relieve inflammation regulating intestinal flora.

Citing Articles

A review on the cultivation, bioactive compounds, health-promoting factors and clinical trials of medicinal mushrooms Taiwanofungus camphoratus, Inonotus obliquus and Tropicoporus linteus.

Tee P, Krishnan T, Cheong X, Maniam S, Looi C, Ooi Y Fungal Biol Biotechnol. 2024; 11(1):7.

PMID: 38987829 PMC: 11238383. DOI: 10.1186/s40694-024-00176-3.

Therapeutic properties of (Chaga mushroom): A review.

Ern P, Quan T, Yee F, Yin A Mycology. 2024; 15(2):144-161.

PMID: 38813471 PMC: 11132974. DOI: 10.1080/21501203.2023.2260408.

Causal Associations between Gut Microbiota and Different Types of Dyslipidemia: A Two-Sample Mendelian Randomization Study.

Zhou X, Lian P, Liu H, Wang Y, Zhou M, Feng Z Nutrients. 2023; 15(20).

PMID: 37892520 PMC: 10609956. DOI: 10.3390/nu15204445.

References

Lee S, Hwang H, Yun J . Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res. 2009; 23(12):1784-9. DOI: 10.1002/ptr.2836. View

Pan H, Jian Y, Wang F, Yu S, Guo J, Kan J . NLRP3 and Gut Microbiota Homeostasis: Progress in Research. Cells. 2022; 11(23). PMC: 9739202. DOI: 10.3390/cells11233758. View

Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X . Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020; 11(1):5015. PMC: 7538905. DOI: 10.1038/s41467-020-18414-8. View

Li C, Schluesener H . Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr. 2015; 57(3):613-631. DOI: 10.1080/10408398.2014.906382. View

Ridlon J, Harris S, Bhowmik S, Kang D, Hylemon P . Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016; 7(1):22-39. PMC: 4856454. DOI: 10.1080/19490976.2015.1127483. View

Shabbir U, Rubab M, Daliri E, Chelliah R, Javed A, Oh D . Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota. Nutrients. 2021; 13(1). PMC: 7828240. DOI: 10.3390/nu13010206. View

Kan J, Wu F, Wang F, Zheng J, Cheng J, Li Y . Phytonutrients: Sources, bioavailability, interaction with gut microbiota, and their impacts on human health. Front Nutr. 2022; 9:960309. PMC: 9424995. DOI: 10.3389/fnut.2022.960309. View

Caporaso J, Kuczynski J, Stombaugh J, Bittinger K, Bushman F, Costello E . QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7(5):335-6. PMC: 3156573. DOI: 10.1038/nmeth.f.303. View

Garadi Z, Dekany M, Moricz A, Gaal A, Papp V, Beni S . Antimicrobial, Antioxidant and Antiproliferative Secondary Metabolites from . Molecules. 2021; 26(18). PMC: 8468361. DOI: 10.3390/molecules26185453. View

10.

Brown G, Kleiner D . Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism. 2016; 65(8):1080-6. PMC: 4889547. DOI: 10.1016/j.metabol.2015.11.008. View

11.

Amor A, Gomez-Guerrero C, Ortega E, Sala-Vila A, Lazaro I . Ellagic Acid as a Tool to Limit the Diabetes Burden: Updated Evidence. Antioxidants (Basel). 2020; 9(12). PMC: 7761821. DOI: 10.3390/antiox9121226. View

12.

Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M . Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017; 131:68-80. DOI: 10.1016/j.ejmech.2017.03.004. View

13.

Xu T, Li G, Wang X, Lv C, Tian Y . Inonotus obliquus polysaccharide ameliorates serum profiling in STZ-induced diabetic mice model. BMC Chem. 2021; 15(1):64. PMC: 8684258. DOI: 10.1186/s13065-021-00789-4. View

14.

Beydoun M, Chen X, Jha K, Beydoun H, Zonderman A, Canas J . Carotenoids, vitamin A, and their association with the metabolic syndrome: a systematic review and meta-analysis. Nutr Rev. 2018; 77(1):32-45. PMC: 6277204. DOI: 10.1093/nutrit/nuy044. View

15.

Yu M, Qi B, Xiaoxiang W, Xu J, Liu X . Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Biomed Pharmacother. 2017; 90:677-685. DOI: 10.1016/j.biopha.2017.04.001. View

16.

Zhao L, Lou H, Peng Y, Chen S, Zhang Y, Li X . Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications. Endocrine. 2019; 66(3):526-537. DOI: 10.1007/s12020-019-02103-8. View

17.

Su L, Xin C, Yang J, Dong L, Mei H, Dai X . A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus. Int J Biol Macromol. 2022; 214:312-323. DOI: 10.1016/j.ijbiomac.2022.06.071. View

18.

Gerard C, Vidal H . Impact of Gut Microbiota on Host Glycemic Control. Front Endocrinol (Lausanne). 2019; 10:29. PMC: 6363653. DOI: 10.3389/fendo.2019.00029. View

19.

Li X, Peng X, Guo K, Tan Z . Bacterial diversity in intestinal mucosa of mice fed with and high-fat diet. 3 Biotech. 2021; 11(1):22. PMC: 7779387. DOI: 10.1007/s13205-020-02558-x. View

20.

Zhang W, Xu J, Yu T, Chen Q . Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. Biomed Pharmacother. 2019; 118:109131. DOI: 10.1016/j.biopha.2019.109131. View